Coinciding with the 2023 International Rare Diseases Day, Frost & Sullivan (Frost & Sullivan, abbreviated as "Frost & Sullivan") and the Beijing Pain Challenge Public Welfare Foundation (abbreviated as "Pain Challenge Foundation") jointly released the "2023 China Rare Diseases Industry Trend Observation Report". The report aims to review and sort out the development of rare diseases in China in terms of diagnosis, medication, care, special medical foods, and innovative services. It outlines the problems faced and progress made in this field over the past, and makes prospects for China's comprehensive rare diseases service system. It is hoped that it will be helpful to policymakers, advocates, practitioners from relevant institutions, family members of patients with rare diseases, and the general public who are concerned about this area.
Frost & Sullivan, in collaboration with the Rare Diseases Foundation, released the '2023 China Rare Disease Industry Trend Observation Report'
Frost & Sullivan, in collaboration with the Rare Diseases Foundation, released the '2023 China Rare Disease Industry Trend Observation Report'
Previous:Frost & Sullivan, in collaboration with the Rare Diseases Foundation, releases the '2023 China Rare Disease Industry Trend Observation Report' | Illuminate Your Life's ColorsNext:Frost & Sullivan releases 'Independent Research Report on China's Industrial Energy Conservation and Environmental Protection Industry'

